Oncology, Domestic Firms Dominate New China Approvals As Innovation Gathers Pace

 
• By Dexter Jie Yan
  
Approvals
Anticancer drugs continue to take up lion’s share of new China approvals • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from China

More from Asia